Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development - HT9425-23-S-SOC1

Active
HT9425-23-S-SOC1-0003Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Broad Agency Announcement (BAA) HT9425-23-S-SOC1 issued by the United States Special Operations Command (USSOCOM) solicits extramural biomedical and human performance research and development to advance scientific knowledge for both military and civilian medical practice. This five-year funding opportunity is continuously open from August 1, 2023, through July 31, 2028, and focuses on basic and applied research rather than the development of specific hardware or systems. The program aims to support innovative medical techniques and materiel for Special Operations Forces operating in challenging, austere, and far-forward environments. Managed through the U.S. Army Medical Research Acquisition Activity (USAMRAA) and the Congressionally Directed Medical Research Programs (CDMRP), the BAA utilizes a trade-off selection process where technical merit, mission relevance to Special Operations Forces, and scientific excellence are the primary drivers for award decisions. The application process follows a mandatory two-step procedure. Interested parties must first submit a pre-proposal through the electronic Biomedical Research Application Portal (eBRAP). If USSOCOM determines the research is of interest, the Principal Investigator will receive an invitation to submit a full proposal via Grants.gov. Proposals must be submitted as discrete PDF attachments following strict naming conventions and page limits, including a project narrative, technical and lay abstracts, and innovation statements. Evaluation factors include research objectives, scientific design excellence, impact, budget realism, and the qualifications of key personnel. While individual award ceilings typically range from $1.5 million to $5 million, the program is subject to annual funding availability. All applicants must be registered in the System for Award Management (SAM) and comply with rigorous requirements regarding conflicts of interest, data management, and the protection of sensitive medical supplies during transport.

General Info

USSOCOM solicits biomedical research funding for Special Operations Forces through 2028.

Agency

Department Of Defense → Defense Health AgencyView Agency

NAICS

54172

Place of Performance

MD

Set-Aside

NONE

Documents

(5)

HT9425-23-S-SOC1 BAA for Extramural Biomedical and Human Performance R&D

PDF50 pagesbaa

HT9425-23-S-SOC1-0003 Broad Agency Announcement for Biomedical Research

PDF50 pagesbaa

FY23-FY28 DoD USSOCOM BAA for Extramural Biomedical & Human Performance Research and Development

PDF51 pagesbaa

FY23-FY28 DoD USSOCOM BAA for Extramural Biomedical & Human Performance Research and Development

PDF51 pagesbaa

FY23-FY28 DoD USSOCOM BAA for Extramural Biomedical & Human Performance Research and Development

PDF52 pagesbaa

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

Posted

special-notice

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Health Agency
Contacts1 person available
OfficeFORT DETRICK, MD, 21702, USA
Organization / Agency
Department Of Defense → Defense Health Agency
View Agency Profile
Office AddressFORT DETRICK, MD, 21702, USA

Full Description

Show more

This BAA is intended to solicit extramural research and development ideas using the authority provided by United States Code, Title 10, Section 4001. This BAA is issued under the provisions of the Competition in Contracting Act of 1984 (Public Law 98-369), as implemented in Federal Acquisition Regulation 6.102(d) (2) and 35.016. In accordance with FAR 6.102, projects funded under this BAA must be for basic and applied research to support scientific study and experimentation directed toward advancing the state-of-the-art or increasing knowledge or understanding rather than focusing on development of a specific system or hardware solution. Research and development funding through this BAA are intended and expected to benefit and inform both military and civilian medical practice and knowledge. This BAA provides a general description of USSOCOM's research and development programs, including research areas of interest, evaluation and selection criteria, pre-proposal/pre-application and full proposal/application preparation instructions, and general administrative information. Submission of a pre-proposal is required. After review, if the USSOCOM is interested in receiving a full proposal, the Offeror will be invited to submit a full proposal or full application. Specific submission information and additional administrative requirements can be found in the document titled "General Submission Instructions" available in Grants.gov along with this BAA The BAA is continuously open for a 5-year period, from 01 August 2023 through 31 July 2028, at 11:59 p.m. Eastern Time. Submission of a pre-proposal is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) (https://eBRAP.org/). Preproposals may be submitted at any time throughout the 5-year period. If the USSOCOM is interested in receiving a full proposal/application, the Principal Investigator will be sent an invitation to submit via eBRAP. A full proposal/application must be submitted through Grants.gov (http://www.grants.gov/). Invited full proposals/applications can be submitted under this BAA through 31 July 2028. The BAA with revised research areas of interests, and General Submission Instructions is available for download on Grants.gov. Search opportunity number HT9425-23-S-SOC1.

More opportunities from Department Of Defense → Defense Health Agency

Same awarding agency

NAICS: 221310
New
Federal
Reverse Osmosis System
Solicitation # HT001426QE043
Solicitation HT001426QE043 is an unrestricted, firm-fixed-price request for offers issued by the Defense Health Agency to procure, deliver, and install a sterile processing critical water system for the Tignor Dental Clinic at Fort Eustis, Virginia. The requirement specifically identifies the Ameri-Water SRB-800-115-FT reverse osmosis system, including a 55-gallon storage tank, distribution pump, phosphate cartridge filter feed system, and UV disinfection system. While originally a brand-name only procurement, Amendment 0001 updated the requirement to brand name or equal and extended the proposal submission deadline to September 16, 2026, by 4:00 PM EST. The contract will be awarded using the Lowest Price Technically Acceptable (LPTA) process, where offers are first evaluated for technical capability and then selected based on the lowest price. The contractor is responsible for all labor, materials, and installation, including final tie-in connections, system commissioning, and the removal of all packaging debris. Delivery is required within 60 days of the order or notice to proceed, with training to be conducted concurrently with or immediately following installation. Compliance with MIL-STD-130 and MIL-STD-129 for item marking and labeling is mandatory, and all payment requests must be processed through the Wide Area WorkFlow system.
Water Supply and Irrigation Systems

POSTED

1 day ago

DEADLINE

in 4 days
View Details
NAICS: 339112
New
Federal
Automated Endoscope Reprocessor (BAMC, San Antonio, Texas)
Solicitation # HT940826QE040
Solicitation HT940826QE040 is a combined synopsis and request for quote issued by the Defense Health Agency for the procurement and installation of five automated endoscope reprocessors (AERs) at Brooke Army Medical Center in San Antonio, Texas. The scope of work includes the installation of units across the Gastroenterology, Pulmonary, and Pediatrics departments, as well as the deinstallation and hauling away of twelve existing Olympus OER Pro/Elite systems. The required AERs must be FDA Class II Medical Devices with 510(k) premarket notification, featuring dual-basin designs with cycle times of approximately 22 minutes and compliance with AS/NI/AAMI ST91 and CDC infection prevention guidelines. The contract also requires the provision of compatible hookup blocks, water filtration assemblies, vapor management accessories, a one-year commercial warranty, and comprehensive on-site clinical training for staff. This is a firm-fixed-price acquisition that is not set aside for small business concerns, though it allows for HUBZone price evaluation preferences. Award will be based on the most advantageous offer, considering price, technical literature demonstrating compliance with specifications, and the delivery and installation timeframe. All items must be delivered by November 15, 2026, and must adhere to DoD item unique identification and marking standards per MIL-STD-130 and MIL-STD-129. Quotes must be submitted electronically to the designated points of contact by September 16, 2026. Payment will be processed electronically through the Wide Area WorkFlow (WAWF) system.
Surgical and Medical Instrument Manufacturing

POSTED

1 day ago

DEADLINE

in 4 days
View Details
NAICS: 621991
New
Federal
Costal Cartilage Allograft (BAMC, San Antonio, Texas)
Solicitation # HT940826QE041
Solicitation HT940826QE041 is a request for quote issued by the Defense Health Agency to procure human donor costal cartilage allografts for surgical reconstruction at Brooke Army Medical Center in San Antonio, Texas. The requirement is for solid, malleable rib cartilage pieces available in various sizes and configurations, including two-piece options, supplied in a saline solution to maintain tissue integrity. The contract is structured as a firm-fixed-price arrangement with an as-needed delivery schedule, featuring a basic requirement and multiple option periods extending through September 30, 2030. Delivery requirements specify that routine orders be shipped promptly, while urgent requirements must be delivered within 48 hours. The acquisition is unrestricted and not set aside for small business concerns, although a 10 percent price evaluation preference is applied to HUBZone and other successful small business concerns. Award will be based on the most advantageous offer, evaluating both price and capability, including FDA and AATB compliance, licensure, and product literature. Contractors must adhere to strict marking and identification standards per MIL-STD-130 and MIL-STD-129, using two-dimensional data matrix symbology. Administrative requirements include the use of Wide Area WorkFlow for invoicing and reporting, and all electronic quotes must be submitted by the September 16, 2026, deadline to the designated points of contact.
Blood and Organ Banks

POSTED

1 day ago

DEADLINE

in 4 days
View Details
NAICS: 339112
New
Federal
Draeger Perseus A500
Solicitation # HT940626QE112
The Defense Health Agency is seeking to negotiate a firm-fixed-price sole source contract with Draeger Inc. for the procurement of seven Draeger Perseus A500 Anesthesia Workstations integrated with the Infinity Acute Care System. These units are intended for Winn Army Community Hospital at Fort Stewart, Georgia, as a one-for-one replacement for existing systems that have reached their ten-year service life. The acquisition includes the workstations, associated components, software licensing, and clinical support services to ensure operational uptime and patient safety. The contractor must be an Original Equipment Manufacturer authorized dealer, distributor, or reseller to maintain OEM warranty and service standards. The delivery is specified as FOB Destination to Fort Stewart, Georgia, with a delivery timeline of approximately eight to ten weeks following the award. The procurement falls under NAICS code 339112 for Surgical and Medical Instrument Manufacturing. While the agency intends to proceed with a sole source award to Draeger Inc. based on clinical standardization and MHS Genesis integration, it has issued a notice of intent allowing other vendors to submit capability statements by September 21, 2026, to challenge the sole source basis. All payment requests and receiving reports must be processed through the Wide Area WorkFlow system.
Surgical and Medical Instrument Manufacturing

POSTED

1 day ago

DEADLINE

in 9 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS